DIA Webinar On How Technology and Collaboration Can Reinvent the Clinical Trial

Share Article

Our webinar will reveal the technology used by savvy life science companies to monitor the clinical trials process using risk-based monitoring. Development strategy experts Laurie Halloran and Irving Dark will explore the rising use of newer statistical methods in remote monitoring in combination with centralized patient databases and new technologies for real-time monitoring, and for site and patient compliance assurance.

DIA and Cytel will co-host a complimentary webinar "Need to Reinvent the Clinical Trial? Innovate, Collaborate and Integrate” on November 20 from 11 a.m. to 12:15 p.m. EDT.    

Many sponsor organizations are wrestling with how to improve the monitoring process with technology in an industry still fresh from the shackles of traditional paper-based data handling. Our webinar will reveal the technology used by savvy life science companies to monitor the clinical trials process using risk-based monitoring.

Development strategy experts Laurie Halloran and Irving Dark will explore the rising use of newer statistical methods in remote monitoring in combination with centralized patient databases and new technologies for real-time monitoring, and for site and patient compliance assurance.
Laurie and Irving will also address bridging the gap between sponsors and clinical research vendors and how best to conduct clinical trials that provide the most reliable information necessary to determine which elements of risk-based monitoring are vital for success, and which may not be necessary.

By conclusion, webinar participants will be familiar with new approaches in clinical development and monitoring of clinical trials, while gaining a fundamental understanding of specific risk-based monitoring techniques.
To register for the Webinar click here.

visit: http://www.diahome.org/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?ProductID=3724975&EventType=Webinar

ABOUT DIA
DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. Our association creates unparalleled opportunities for regulators, innovators and influencers in the life cycle product development process to exchange knowledge and collaborate in a neutral setting. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA, and regional offices covering the Americas (Horsham, Pa., USA); Europe, Africa and the Middle East (Basel, Switzerland); and Asia (Tokyo, Mumbai and Beijing). For more information, visit http://www.diahome.org.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Press Contact
Visit website